Peter Shalit, MD, PhD

HIV Specialist
Seattle, WA, United States

Disclosure(s): Gilead Sciences: Grant/Research Support, Honoraria; ViiV Healthcare: Advisor/Consultant, Grant/Research Support, Honoraria

Presentation(s):

• 506 - Week 26 Interim Analysis of Implementation and Delivery of Long-Acting Injectable Cabotegravir for PrEP in a Community Pharmacy Setting

  Saturday, October 19, 2024
  11:00 AM – 11:15 AM US PT